Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study in adolescents evaluating the safety and efficacy of dexlansoprazole delayed-release capsules for healing erosive esophagitis, maintaining healed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease, Erosive Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2015-05-27